Skip to main content
Erschienen in: Cancer Causes & Control 6/2011

01.06.2011 | Original paper

Height at diagnosis and birth-weight as risk factors for osteosarcoma

Erschienen in: Cancer Causes & Control | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Osteosarcoma typically occurs during puberty. Studies of the association between height and/or birth-weight and osteosarcoma are conflicting. Therefore, we conducted a large pooled analysis of height and birth-weight in osteosarcoma.

Methods

Patient data from seven studies of height and three of birth-weight were obtained, resulting in 1,067 cases with height and 434 cases with birth-weight data. We compared cases to the 2000 US National Center for Health Statistics Growth Charts by simulating 1,000 age- and gender-matched controls per case. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for associations between height or birth-weight and risk of osteosarcoma for each study were estimated using logistic regression. All of the case data were combined for an aggregate analysis.

Results

Compared to average birth-weight subjects (2,665–4,045 g), individuals with high birth-weight (≥4,046 g) had an increased osteosarcoma risk (OR 1.35, 95% CI 1.01–1.79). Taller than average (51st–89th percentile) and very tall individuals (≥90th percentile) had an increased risk of osteosarcoma (OR 1.35, 95% CI 1.18–1.54 and OR 2.60, 95% CI 2.19–3.07, respectively; P trend < 0.0001).

Conclusions

This is the largest analysis of height at diagnosis and birth-weight in relation to osteosarcoma. It suggests that rapid bone growth during puberty and in utero contributes to OS etiology.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mascarenhas L, Siegel S, Spector L, Arndt C, Femino D, Malogolowkin M (2006) Malignant bone tumors: cancer in 15- to 29-year-olds in the United States. In: Bleyer AOLM, Barr R, Ries LAG (eds) Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. National Cancer Institute, Bethesda NIH Pub. No. 06-5767, pp 98–109 Mascarenhas L, Siegel S, Spector L, Arndt C, Femino D, Malogolowkin M (2006) Malignant bone tumors: cancer in 15- to 29-year-olds in the United States. In: Bleyer AOLM, Barr R, Ries LAG (eds) Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. National Cancer Institute, Bethesda NIH Pub. No. 06-5767, pp 98–109
2.
Zurück zum Zitat Dahlin DC, Unni KK (1986) Bone Tumors: general aspects and data on 8, 542 cases, 4th ed edn. Thomas, Springfield Dahlin DC, Unni KK (1986) Bone Tumors: general aspects and data on 8, 542 cases, 4th ed edn. Thomas, Springfield
3.
Zurück zum Zitat Dorfman HA, Czerniak B (1995) Bone cancers. Cancer Suppl 75:203–210 Dorfman HA, Czerniak B (1995) Bone cancers. Cancer Suppl 75:203–210
4.
5.
Zurück zum Zitat Hanson MF, Seton M, Merchant A (2006) Osteosarcoma in Paget’s disease of bone. J Bone Miner Res 21:P58–P63CrossRef Hanson MF, Seton M, Merchant A (2006) Osteosarcoma in Paget’s disease of bone. J Bone Miner Res 21:P58–P63CrossRef
6.
7.
Zurück zum Zitat Chauveinc L, Mosseri V, Quintana E et al (2001) Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet 22:77–88PubMedCrossRef Chauveinc L, Mosseri V, Quintana E et al (2001) Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet 22:77–88PubMedCrossRef
8.
Zurück zum Zitat Lipton JM, Federman N, Khabbaze Y et al (2001) Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry. J Pediatr Hematol Oncol 23:39–44PubMedCrossRef Lipton JM, Federman N, Khabbaze Y et al (2001) Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry. J Pediatr Hematol Oncol 23:39–44PubMedCrossRef
9.
Zurück zum Zitat Wang LL, Gannavarapu A, Kozinetz CA et al (2003) Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. J Natl Cancer Inst 95:669–674PubMedCrossRef Wang LL, Gannavarapu A, Kozinetz CA et al (2003) Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. J Natl Cancer Inst 95:669–674PubMedCrossRef
10.
Zurück zum Zitat Mirabello L, Troisi RJ, Savage S (2009) Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer 115:1531–1543PubMedCrossRef Mirabello L, Troisi RJ, Savage S (2009) Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer 115:1531–1543PubMedCrossRef
11.
Zurück zum Zitat Unni KK (1996) Dahlin’s bone tumors: general aspects and data on 11,087 cases. In. 5 edn. Philadelphia: Lippincott-Raven, pp 143–183 Unni KK (1996) Dahlin’s bone tumors: general aspects and data on 11,087 cases. In. 5 edn. Philadelphia: Lippincott-Raven, pp 143–183
12.
Zurück zum Zitat Dorfman HA, Czerniak B (1997) Bone tumors. St. Louis, Mosby, pp 128–252 Dorfman HA, Czerniak B (1997) Bone tumors. St. Louis, Mosby, pp 128–252
13.
Zurück zum Zitat Glass AG, Fraumeni JF (1970) Epidemiology of bone cancer in children. J Natl Cancer Inst 44:187–199PubMed Glass AG, Fraumeni JF (1970) Epidemiology of bone cancer in children. J Natl Cancer Inst 44:187–199PubMed
14.
Zurück zum Zitat Miller RW (1981) Contrasting epidemiology of childhood osteosarcoma, Ewing’s sarcoma, and rhabdomyosarcoma. Nat Cancer Inst Monogr 56:9–15PubMed Miller RW (1981) Contrasting epidemiology of childhood osteosarcoma, Ewing’s sarcoma, and rhabdomyosarcoma. Nat Cancer Inst Monogr 56:9–15PubMed
15.
Zurück zum Zitat Withrow SJ, Powers BE, Straw RC, RM Wilkins (1991) Comparative aspects of osteosarcoma. Dog versus man. Clin Orthop Relat Res 270:159–168PubMed Withrow SJ, Powers BE, Straw RC, RM Wilkins (1991) Comparative aspects of osteosarcoma. Dog versus man. Clin Orthop Relat Res 270:159–168PubMed
16.
Zurück zum Zitat Tjalma RA (1966) Canine bone sarcoma: estimation of relative risk as a function of body size. J Natl Cancer Inst 36:1137–1150PubMed Tjalma RA (1966) Canine bone sarcoma: estimation of relative risk as a function of body size. J Natl Cancer Inst 36:1137–1150PubMed
17.
Zurück zum Zitat Fraumeni JF Jr (1967) Stature and malignant tumors of the bone in childhood and adolescence. Cancer 20:967–973PubMedCrossRef Fraumeni JF Jr (1967) Stature and malignant tumors of the bone in childhood and adolescence. Cancer 20:967–973PubMedCrossRef
18.
Zurück zum Zitat Troisi R, Masters MN, Joshipura K et al (2006) Perinatal factors, growth and development, and osteosarcoma risk. Br J Cancer 95:1603–1607PubMedCrossRef Troisi R, Masters MN, Joshipura K et al (2006) Perinatal factors, growth and development, and osteosarcoma risk. Br J Cancer 95:1603–1607PubMedCrossRef
19.
Zurück zum Zitat Scranton PE, DeCicco FA, Totten RS, Yunis EJ (1975) Prognostic factors in osteosarcoma. A review of 20 years’ experience at the University of Pittsburgh Health Center Hospitals. Cancer 36:2179–2191PubMedCrossRef Scranton PE, DeCicco FA, Totten RS, Yunis EJ (1975) Prognostic factors in osteosarcoma. A review of 20 years’ experience at the University of Pittsburgh Health Center Hospitals. Cancer 36:2179–2191PubMedCrossRef
20.
Zurück zum Zitat Gelberg KH, Fitzgerald E, Hwang S, Dubrow R (1997) Growth and development and other risk factors for osteosarcoma in children and young adults. Int J Epidemiol 26:272–278PubMedCrossRef Gelberg KH, Fitzgerald E, Hwang S, Dubrow R (1997) Growth and development and other risk factors for osteosarcoma in children and young adults. Int J Epidemiol 26:272–278PubMedCrossRef
21.
Zurück zum Zitat Rytting M, Pearson P, Raymond AK et al (2000) Osteosarcoma in preadolescent patients. Clin Orthop Relat Res 373:39–50PubMedCrossRef Rytting M, Pearson P, Raymond AK et al (2000) Osteosarcoma in preadolescent patients. Clin Orthop Relat Res 373:39–50PubMedCrossRef
22.
Zurück zum Zitat Ruza E, Sotillo E, Sierrasesúmaga L, Azcona C, Patiño-Garcia A (2003) Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Iα1 genes and their relationship with height in children with bone cancer. J Pediatr Hematol Oncol 25:780–786PubMedCrossRef Ruza E, Sotillo E, Sierrasesúmaga L, Azcona C, Patiño-Garcia A (2003) Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Iα1 genes and their relationship with height in children with bone cancer. J Pediatr Hematol Oncol 25:780–786PubMedCrossRef
23.
Zurück zum Zitat Cotterill SJ, Wright CM, Pearce MS, Craft AW (2004) Stature of young people with malignant bone tumors. Pediatr Blood Cancer 42:59–63PubMedCrossRef Cotterill SJ, Wright CM, Pearce MS, Craft AW (2004) Stature of young people with malignant bone tumors. Pediatr Blood Cancer 42:59–63PubMedCrossRef
24.
Zurück zum Zitat Longhi A, Pasini A, Cicognami A et al (2005) Height as a risk factor for osteosarcoma. J Pediatr Hematol Oncol 27:314–318PubMedCrossRef Longhi A, Pasini A, Cicognami A et al (2005) Height as a risk factor for osteosarcoma. J Pediatr Hematol Oncol 27:314–318PubMedCrossRef
25.
Zurück zum Zitat Goodman MA, McMaster JH, Drash AL et al (1978) Metabolic and endocrine alterations in osteosarcoma patients. Cancer 42:603–610PubMedCrossRef Goodman MA, McMaster JH, Drash AL et al (1978) Metabolic and endocrine alterations in osteosarcoma patients. Cancer 42:603–610PubMedCrossRef
26.
Zurück zum Zitat Broström LA, Adamson U, Filipsson R, Hall K (1979) Longitudinal growth and dental development in osteosarcoma patients. Acta Orthop Scand 51:755–759 Broström LA, Adamson U, Filipsson R, Hall K (1979) Longitudinal growth and dental development in osteosarcoma patients. Acta Orthop Scand 51:755–759
27.
Zurück zum Zitat Vassilopoulou-Sellin R, Wallis CJ, Samaan NA (1985) Hormonal evaluation in patients with osteosarcoma. J Surg Oncol 28:209–213PubMedCrossRef Vassilopoulou-Sellin R, Wallis CJ, Samaan NA (1985) Hormonal evaluation in patients with osteosarcoma. J Surg Oncol 28:209–213PubMedCrossRef
28.
Zurück zum Zitat Operskalski EA, Preston-Martin S, Henderson BE, Visscher BR (1987) A case-control study of osteosarcoma in young persons. Am J Epidemiol 126:118–126PubMed Operskalski EA, Preston-Martin S, Henderson BE, Visscher BR (1987) A case-control study of osteosarcoma in young persons. Am J Epidemiol 126:118–126PubMed
29.
Zurück zum Zitat Pui CH, Dodge RK, George SL, Green AA (1987) Height at diagnosis of malignancies. Arch Dis Child 62:495–499PubMedCrossRef Pui CH, Dodge RK, George SL, Green AA (1987) Height at diagnosis of malignancies. Arch Dis Child 62:495–499PubMedCrossRef
30.
Zurück zum Zitat Glasser DB, Duane K, Lane JM, Healey JH, Caparros-Sison B (1991) The effect of chemotherapy on growth in the skeletally immature individual. Clin Orthop Relat Res 262:93–100PubMed Glasser DB, Duane K, Lane JM, Healey JH, Caparros-Sison B (1991) The effect of chemotherapy on growth in the skeletally immature individual. Clin Orthop Relat Res 262:93–100PubMed
31.
Zurück zum Zitat Buckley JD, Pendergrass TW, Buckley CM et al (1998) Epidemiology of osteosarcoma and Ewing’s sarcoma in children: a study of 305 cases by the Children’s Cancer Group. Cancer 83:1440–1448PubMedCrossRef Buckley JD, Pendergrass TW, Buckley CM et al (1998) Epidemiology of osteosarcoma and Ewing’s sarcoma in children: a study of 305 cases by the Children’s Cancer Group. Cancer 83:1440–1448PubMedCrossRef
32.
Zurück zum Zitat Cool WP, Grimer RJ, Carter SR, Tillman RM, Davies AM (1998) Longitudinal growth following treatment for osteosarcoma. Sarcoma 2:115–119PubMedCrossRef Cool WP, Grimer RJ, Carter SR, Tillman RM, Davies AM (1998) Longitudinal growth following treatment for osteosarcoma. Sarcoma 2:115–119PubMedCrossRef
33.
Zurück zum Zitat Hartley AL, Birch JM, McKinney PA et al (1988) The inter-regional epidemiological study of childhood cancer (IRESCC): case control study of children with bone and soft tissue sarcomas. Br J Cancer 58:838–842PubMedCrossRef Hartley AL, Birch JM, McKinney PA et al (1988) The inter-regional epidemiological study of childhood cancer (IRESCC): case control study of children with bone and soft tissue sarcomas. Br J Cancer 58:838–842PubMedCrossRef
34.
Zurück zum Zitat Schüz J, Forman MR (2007) Birthweight by gestational age and childhood cancer. Cancer Causes Control 18:655–663PubMedCrossRef Schüz J, Forman MR (2007) Birthweight by gestational age and childhood cancer. Cancer Causes Control 18:655–663PubMedCrossRef
35.
Zurück zum Zitat Schuz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J (1999) Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 28:631–639PubMedCrossRef Schuz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J (1999) Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 28:631–639PubMedCrossRef
36.
Zurück zum Zitat Kuczmarski RJ, Ogden CL, Guo SS et al (2002) 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11:1–190 Kuczmarski RJ, Ogden CL, Guo SS et al (2002) 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11:1–190
37.
Zurück zum Zitat Hernández M, Castellet J, Narvaiza JL et al (1988) Curvas y tablas de crecimiento. Instituto de investigación sobre crecimiento y desarrollo. Orbegozo Editorial Garsi, Fundación F. Madrid Hernández M, Castellet J, Narvaiza JL et al (1988) Curvas y tablas de crecimiento. Instituto de investigación sobre crecimiento y desarrollo. Orbegozo Editorial Garsi, Fundación F. Madrid
38.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRef DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRef
39.
Zurück zum Zitat Higgins JP (2008) Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 37:1158–1160PubMedCrossRef Higgins JP (2008) Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 37:1158–1160PubMedCrossRef
40.
Zurück zum Zitat Egger M, Davey-Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629–634 Egger M, Davey-Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629–634
41.
Zurück zum Zitat Begg CB, Mazumdar M (1994) Operating characteristics of rank correlation test for publication bias. Biometrics 50:1088–1101PubMedCrossRef Begg CB, Mazumdar M (1994) Operating characteristics of rank correlation test for publication bias. Biometrics 50:1088–1101PubMedCrossRef
42.
Zurück zum Zitat Hjalgrim LL, Westergaard T, Rostgaard K et al (2003) Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am J Epidemiol 158:724–735PubMedCrossRef Hjalgrim LL, Westergaard T, Rostgaard K et al (2003) Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am J Epidemiol 158:724–735PubMedCrossRef
43.
Zurück zum Zitat Harder T, Plagemann A, Harder A (2008) Birth weight and subsequent risk of childhood primary brain tumors: a meta-analysis. Am J Epidemiol 168:366–373PubMedCrossRef Harder T, Plagemann A, Harder A (2008) Birth weight and subsequent risk of childhood primary brain tumors: a meta-analysis. Am J Epidemiol 168:366–373PubMedCrossRef
44.
Zurück zum Zitat Harder T, Plagemann A, Harder A (2010) Birth weight and risk of neuroblastoma: a meta-analysis. Int J Epidemiol 39:746–756PubMedCrossRef Harder T, Plagemann A, Harder A (2010) Birth weight and risk of neuroblastoma: a meta-analysis. Int J Epidemiol 39:746–756PubMedCrossRef
45.
Zurück zum Zitat Ognjanovic S, Carozza SE, Chow EJ et al. (2009) Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype. Br J Cancer Dec 8. [Epub ahead of print] Ognjanovic S, Carozza SE, Chow EJ et al. (2009) Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype. Br J Cancer Dec 8. [Epub ahead of print]
46.
Zurück zum Zitat Leisenring WM, Breslow NE, Evans IE et al (1994) Increased birth weights of National Wilms’ Tumor Study patients suggest a growth factor excess. Cancer Res 54:4680–4683PubMed Leisenring WM, Breslow NE, Evans IE et al (1994) Increased birth weights of National Wilms’ Tumor Study patients suggest a growth factor excess. Cancer Res 54:4680–4683PubMed
47.
Zurück zum Zitat Schüz J, Schmidt LS, Kogner P et al. (2010) Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control study. Int J Cancer [Epub ahead of print] Schüz J, Schmidt LS, Kogner P et al. (2010) Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control study. Int J Cancer [Epub ahead of print]
48.
Zurück zum Zitat Smith A, Lightfoot T, Simpson J, Roman E, UKCCS investigators (2009) Birth weight, sex and childhood cancer: a report from the United Kingdom Childhood Cancer Study. Cancer Epidemiol Biomarkers Prev 33:363–367 Smith A, Lightfoot T, Simpson J, Roman E, UKCCS investigators (2009) Birth weight, sex and childhood cancer: a report from the United Kingdom Childhood Cancer Study. Cancer Epidemiol Biomarkers Prev 33:363–367
49.
Zurück zum Zitat Crowther NJ, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486PubMedCrossRef Crowther NJ, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486PubMedCrossRef
50.
Zurück zum Zitat Ross JA, Perentesis JP, Robison LL, Davies SM (1996) Big babies and infant leukemia: a role for insulin-like growth factor-1? Cancer Causes Control 7:553–559PubMedCrossRef Ross JA, Perentesis JP, Robison LL, Davies SM (1996) Big babies and infant leukemia: a role for insulin-like growth factor-1? Cancer Causes Control 7:553–559PubMedCrossRef
51.
Zurück zum Zitat Murphy VE, Smith R, Giles WB, Clifton VL (2006) Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev 27:141–169PubMedCrossRef Murphy VE, Smith R, Giles WB, Clifton VL (2006) Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev 27:141–169PubMedCrossRef
52.
Zurück zum Zitat Furstenberger G, Senn HJ (2002) Insulin-like growth factors and cancer. Lancet Oncol 3:298–302PubMedCrossRef Furstenberger G, Senn HJ (2002) Insulin-like growth factors and cancer. Lancet Oncol 3:298–302PubMedCrossRef
53.
Zurück zum Zitat Lagiou P, Hsieh CC, Lipworth L et al (2009) Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk. Br J Cancer 100:1794–1798PubMedCrossRef Lagiou P, Hsieh CC, Lipworth L et al (2009) Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk. Br J Cancer 100:1794–1798PubMedCrossRef
54.
Zurück zum Zitat Raqib R, Alam DS, Sarker P et al (2007) Low birth weight is associated with altered immune function in rural Bangladeshi children: a birth cohort study. Am J Clin Nutr 85:845–852PubMed Raqib R, Alam DS, Sarker P et al (2007) Low birth weight is associated with altered immune function in rural Bangladeshi children: a birth cohort study. Am J Clin Nutr 85:845–852PubMed
55.
Zurück zum Zitat Charalambous M, da Rocha ST, Ferguson-Smith AC (2007) Genomic imprinting, growth control and the allocation of nutritional resources: consequences for postnatal life. Curr Opin Endocrinol Diabetes Obes 14:3–12PubMedCrossRef Charalambous M, da Rocha ST, Ferguson-Smith AC (2007) Genomic imprinting, growth control and the allocation of nutritional resources: consequences for postnatal life. Curr Opin Endocrinol Diabetes Obes 14:3–12PubMedCrossRef
56.
Zurück zum Zitat Michels KB, Xue F (2006) Role of birth weight in the etiology of breast cancer. Int J Cancer 119:2007–2025PubMedCrossRef Michels KB, Xue F (2006) Role of birth weight in the etiology of breast cancer. Int J Cancer 119:2007–2025PubMedCrossRef
57.
Zurück zum Zitat Eriksson M, Wedel H, Wallander MA et al (2007) The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age. Prostate 67:1247–1254PubMedCrossRef Eriksson M, Wedel H, Wallander MA et al (2007) The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age. Prostate 67:1247–1254PubMedCrossRef
58.
Zurück zum Zitat Cnattingius S, Lundberg F, Sandin S, Grönberg H, Iliadou A (2009) Birth characteristics and risk of prostate cancer: the contribution of genetic factors. Cancer Epidemiol Biomarkers Prev 18:2422–2426PubMedCrossRef Cnattingius S, Lundberg F, Sandin S, Grönberg H, Iliadou A (2009) Birth characteristics and risk of prostate cancer: the contribution of genetic factors. Cancer Epidemiol Biomarkers Prev 18:2422–2426PubMedCrossRef
59.
Zurück zum Zitat Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. Part I. Arch Dis Child 41:454–471PubMedCrossRef Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. Part I. Arch Dis Child 41:454–471PubMedCrossRef
60.
Zurück zum Zitat Larsson SE, Lorentzon R (1974) The incidence of malignant primary bone tumours in relation to age, sex and site—a study of osteogenic sarcoma, chondrosarcoma and Ewing’s sarcoma diagnosed in Sweden from 1958 to 1968. J Bone Joint Surg 56-B:534–540 Larsson SE, Lorentzon R (1974) The incidence of malignant primary bone tumours in relation to age, sex and site—a study of osteogenic sarcoma, chondrosarcoma and Ewing’s sarcoma diagnosed in Sweden from 1958 to 1968. J Bone Joint Surg 56-B:534–540
61.
Zurück zum Zitat Price CHG (1958) Primary bone-forming tumours and their relationship to skeletal growth. J Bone Joint Surg 408:574–593 Price CHG (1958) Primary bone-forming tumours and their relationship to skeletal growth. J Bone Joint Surg 408:574–593
62.
Zurück zum Zitat Fraumeni JF Jr, Boice JD (1982) Bone. In: DFJJ Schottenfeld (ed) Cancer epidemiology and prevention. W B Saunders Co, Philadelphia Fraumeni JF Jr, Boice JD (1982) Bone. In: DFJJ Schottenfeld (ed) Cancer epidemiology and prevention. W B Saunders Co, Philadelphia
63.
Zurück zum Zitat Mirabello L, Troisi RJ, Savage SA (2009) International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 125:229–234PubMedCrossRef Mirabello L, Troisi RJ, Savage SA (2009) International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 125:229–234PubMedCrossRef
64.
Zurück zum Zitat Ru G, Terracini B, Glickman LT (1998) Host related risk factors for canine osteosarcoma. Vet J 156:31–39PubMedCrossRef Ru G, Terracini B, Glickman LT (1998) Host related risk factors for canine osteosarcoma. Vet J 156:31–39PubMedCrossRef
65.
Zurück zum Zitat Ruddon RW (1987) Cancer biology. Oxford University Press, New York Ruddon RW (1987) Cancer biology. Oxford University Press, New York
66.
Zurück zum Zitat Savage SA, Woodson K, Walk E et al (2007) Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 16:1667–1674PubMedCrossRef Savage SA, Woodson K, Walk E et al (2007) Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 16:1667–1674PubMedCrossRef
67.
Zurück zum Zitat Kappel CC, Velez-Yanguas MC, Hirschfeld S, Helman LJ (1994) Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res 54:2803–2807PubMed Kappel CC, Velez-Yanguas MC, Hirschfeld S, Helman LJ (1994) Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res 54:2803–2807PubMed
68.
Zurück zum Zitat Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505–518PubMedCrossRef Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505–518PubMedCrossRef
Metadaten
Titel
Height at diagnosis and birth-weight as risk factors for osteosarcoma
Publikationsdatum
01.06.2011
Erschienen in
Cancer Causes & Control / Ausgabe 6/2011
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-011-9763-2

Weitere Artikel der Ausgabe 6/2011

Cancer Causes & Control 6/2011 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.